PA
CABA icon

Profund Advisors’s Cabaletta Bio CABA Stock Holding History

Profund Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+73,409
New +$241K 0.01% 996
2024
Q3 		– Sell
-19,250
Closed -$144K – 1135
2024
Q2 		$144K Sell
19,250
-35,177
-65% -$431K 0.01% 1022
2024
Q1 		$929K Buy
54,427
+20,569
+61% +$441K 0.04% 375
2023
Q4 		$769K Buy
33,858
+13,737
+68% +$231K 0.03% 392
2023
Q3 		$306K Buy
+20,121
New +$275K 0.02% 656

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Profund Advisors's CABA Position: Q2 2026 in Review

Profund Advisors opened a new position in Cabaletta Bio (CABA) in Q2 2026: 73,409 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #996 among its holdings. This is a return to the name: Profund Advisors previously reported a position in CABA as recently as Q2 2024.

Profund Advisors first reported a position in CABA in Q3 2023 and has held it in 5 quarters since. The position peaked at $929K in Q1 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Profund Advisors held 73,409 shares of Cabaletta Bio worth $228K as of Q2 2026.
  • Cabaletta Bio was a new Profund Advisors position in Q2 2026.
  • Cabaletta Bio made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #996 holding.
  • Profund Advisors first reported a position in Cabaletta Bio in Q3 2023 and has held it in 5 quarters since.
  • Profund Advisors's Cabaletta Bio position peaked at $929K in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.